Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PT-112”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Testing effectiveness (Phase 2)UnknownNCT02884479
What this trial is testing

An Open-Label Phase I/II Clinical Study of PT-112 in Combination With Docetaxel in Subjects With Advanced Solid Tumor in a Phase I Dose Escalation Study and in Subjects With Non-Small Cell Lung Cancer (NSCLC) in a Phase II Dose Confirmation Study

Who this might be right for
Advanced Solid TumorNon-Small Cell Lung Cancer
SciClone Pharmaceuticals International (Cayman) Development Limited 75
Testing effectiveness (Phase 2)Looking for participantsNCT05104736
What this trial is testing

PT-112 in Subjects With Thymoma and Thymic Carcinoma

Who this might be right for
Thymic Epithelial TumorRecurrent ThymomaThymic Cancer
National Cancer Institute (NCI) 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT02266745
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts

Who this might be right for
Advanced Solid TumorsCRPCmCRPC+6 more
Promontory Therapeutics Inc. 109
Testing effectiveness (Phase 2)Study completedNCT03409458
What this trial is testing

A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Promontory Therapeutics Inc. 68
Testing effectiveness (Phase 2)UnknownNCT03439761
What this trial is testing

An Open-label Phase I/II Clinical Trial of PT-112 Injection for Advanced Solid Tumors and Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Solid Tumors
SciClone Pharmaceuticals 125
Early research (Phase 1)Study completedNCT03288480
What this trial is testing

A Phase 1/2a Dose-Finding Study of PT-112 in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Promontory Therapeutics Inc. 24
Testing effectiveness (Phase 2)UnknownNCT05357196
What this trial is testing

PT-112 (Phosplatin's Platinum) Combine With Gemcitabine Injection for Advanced Solid Tumors

Who this might be right for
Biliary Tract Cancer
SciClone Pharmaceuticals 68